Michael Doukas

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

Bo Jan Noordman, Manon C.W. Spaander, Roelf Valkema et al. · The Lancet Oncology · 2018 · 332 citations

Medicine, Oncology, Surgery +17

Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial

Bo Jan Noordman, Bas P. L. Wijnhoven, Sjoerd M. Lagarde et al. · BMC Cancer · 2018 · 245 citations · Full text

Medicine, Oncology, Surgery +17

Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions

Wouter J. den Hollander, Ingrid L. Holster, Caroline M. den Hoed et al. · Gut · 2018 · 158 citations

Medicine, Oncology, Pathology +17

Potentiation of Peptide Receptor Radionuclide Therapy by the PARP Inhibitor Olaparib

Julie Nonnekens, Melissa van Kranenburg, Cecile Beerens et al. · Theranostics · 2016 · 137 citations · Full text

Medicine, Molecular Biology, Oncology +17

Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice

Danny Halim, Michael P. Wilson, Daniel Oliver et al. · Proceedings of the National Academy of Sciences · 2017 · 127 citations · Full text

Life Sciences, Cell Biology, Genetics +12